Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial.
Boas R, Thune JJ, Pehrson S, Køber L, Nielsen JC, Videbæk L, Haarbo J, Korup E, Bruun NE, Brandes A, Eiskjær H, Thøgersen AM, Philbert BT, Svendsen JH, Dixen U.
Boas R, et al. Among authors: philbert bt.
Am Heart J. 2021 Feb;232:61-70. doi: 10.1016/j.ahj.2020.10.073. Epub 2020 Nov 2.
Am Heart J. 2021.
PMID: 33144085